Shares of Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA) have recently risen to a new 52-week high. The stock has been seen at $8.57 after a recent session check. Over the last 5 trading periods, the stock has seen a move of 2.48%.EPS Watch
Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA)’s EPS growth this year is 7.10% and the trailing 12-month EPS is $-3.43. Covering sell-side analysts are estimating company growth for next year to be 7.70%. On a consensus basis, analysts have given a recommendation of 2.20 on company shares.
Since the start of the calendar year, Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA)’s stock has changed 186.81%. Over the last five trading sessions, the stock has moved 2.48%. For the past month, Dicerna Pharmaceuticals, Inc.’s stock has been 55.85%, 153.37% for the last quarter, 169.06% for the past six months and 120.86% for the past 52 weeks.
Based on current stock levels, Dicerna Pharmaceuticals, Inc. shares are trading 1.06% off of the 50-day high and 172.06% away from the 50-day low.
Disclaimer: The views, opinions, and information expressed in this article are those of the authors and do not necessarily reflect the official policy or position of any company stakeholders, financial professionals, or analysts. Examples of analysis performed within this article are only examples.